000 | 01967 a2200469 4500 | ||
---|---|---|---|
005 | 20250515161902.0 | ||
264 | 0 | _c20090811 | |
008 | 200908s 0 0 eng d | ||
022 | _a1552-5783 | ||
024 | 7 |
_a10.1167/iovs.08-3168 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDalsgaard, Thomas | |
245 | 0 | 0 |
_aRole of calcium-activated potassium channels with small conductance in bradykinin-induced vasodilation of porcine retinal arterioles. _h[electronic resource] |
260 |
_bInvestigative ophthalmology & visual science _cAug 2009 |
||
300 |
_a3819-25 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
650 | 0 | 4 |
_aArterioles _xphysiology |
650 | 0 | 4 |
_aBradykinin _xpharmacology |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 |
_aIndoles _xpharmacology |
650 | 0 | 4 |
_aIndomethacin _xpharmacology |
650 | 0 | 4 |
_aIntermediate-Conductance Calcium-Activated Potassium Channels _xphysiology |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xantagonists & inhibitors |
650 | 0 | 4 |
_aOximes _xpharmacology |
650 | 0 | 4 |
_aRetinal Artery _xphysiology |
650 | 0 | 4 |
_aSmall-Conductance Calcium-Activated Potassium Channels _xphysiology |
650 | 0 | 4 | _aSwine |
650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
650 | 0 | 4 |
_aVasodilation _xphysiology |
650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
700 | 1 | _aKroigaard, Christel | |
700 | 1 | _aBek, Toke | |
700 | 1 | _aSimonsen, Ulf | |
773 | 0 |
_tInvestigative ophthalmology & visual science _gvol. 50 _gno. 8 _gp. 3819-25 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1167/iovs.08-3168 _zAvailable from publisher's website |
999 |
_c18696187 _d18696187 |